Related Experiment Video
Updated: Jun 5, 2026

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Sertraline-induced pseudocholinesterase enzyme deficiency
1MOSTAS Private Health Hospital, Department of Anesthesiology, Kahramanmaras, Turkey.
Patients with pseudocholinesterase deficiency may experience prolonged paralysis after anesthesia. This case highlights the importance of recognizing enzyme deficiency and managing it with supportive care, not medication.
Area of Science:
- Anesthesiology
- Pharmacogenetics
Background:
- Pseudocholinesterase is crucial for metabolizing muscle relaxants like succinylcholine.
- Deficiency can cause prolonged apnea and paralysis post-anesthesia.
- Sertraline use was noted in the patient's history.
Observation:
- A 47-year-old male undergoing laparoscopic cholecystectomy had a history of anesthesia without complications.
- He received succinylcholine in prior surgeries.
- This time, prolonged paralysis was observed post-administration.
Findings:
- The patient exhibited low plasma cholinesterase activity, indicating pseudocholinesterase deficiency.
- Diagnosis was supported by clinical observation and peripheral nerve stimulator monitoring.
- The prolonged neuromuscular block resolved over time with supportive care.
Implications:
- Highlights the importance of identifying pseudocholinesterase deficiency in patients with unexpected prolonged paralysis.
- Suggests supportive care (sedation, mechanical ventilation) is preferred over pharmacological intervention.
- Emphasizes careful patient monitoring to prevent complications in such cases.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Pharmocokinetics
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
